X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs CADILA HEALTHCARE - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD CADILA HEALTHCARE ALEMBIC LTD/
CADILA HEALTHCARE
 
P/E (TTM) x 75.7 34.8 217.7% View Chart
P/BV x 2.8 9.0 31.4% View Chart
Dividend Yield % 0.4 0.7 58.4%  

Financials

 ALEMBIC LTD   CADILA HEALTHCARE
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
CADILA HEALTHCARE
Mar-16
ALEMBIC LTD/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs53454 11.6%   
Low Rs29305 9.6%   
Sales per share (Unadj.) Rs4.796.1 4.9%  
Earnings per share (Unadj.) Rs8.814.9 59.0%  
Cash flow per share (Unadj.) Rs9.017.8 50.5%  
Dividends per share (Unadj.) Rs0.153.20 4.7%  
Dividend yield (eoy) %0.40.8 43.3%  
Book value per share (Unadj.) Rs27.752.3 53.0%  
Shares outstanding (eoy) m267.031,023.74 26.1%   
Bonus/Rights/Conversions -FV5:1-  
Price / Sales ratio x8.73.9 220.3%   
Avg P/E ratio x4.725.5 18.3%  
P/CF ratio (eoy) x4.621.3 21.4%  
Price / Book Value ratio x1.57.3 20.4%  
Dividend payout %1.721.5 7.9%   
Avg Mkt Cap Rs m10,962388,458 2.8%   
No. of employees `000NA15.4 0.0%   
Total wages/salary Rs m23813,317 1.8%   
Avg. sales/employee Rs ThNM6,371.1-  
Avg. wages/employee Rs ThNM862.4-  
Avg. net profit/employee Rs ThNM986.1-  
INCOME DATA
Net Sales Rs m1,26098,376 1.3%  
Other income Rs m264941 28.0%   
Total revenues Rs m1,52499,317 1.5%   
Gross profit Rs m8323,829 0.3%  
Depreciation Rs m613,022 2.0%   
Interest Rs m0486 0.1%   
Profit before tax Rs m28521,262 1.3%   
Minority Interest Rs m0-300 0.0%   
Prior Period Items Rs m2,0965 41,924.0%   
Extraordinary Inc (Exp) Rs m-32-25 128.8%   
Tax Rs m65,716 0.1%   
Profit after tax Rs m2,34315,226 15.4%  
Gross profit margin %6.624.2 27.1%  
Effective tax rate %2.126.9 8.0%   
Net profit margin %185.915.5 1,201.1%  
BALANCE SHEET DATA
Current assets Rs m1,68944,376 3.8%   
Current liabilities Rs m48634,071 1.4%   
Net working cap to sales %95.410.5 910.9%  
Current ratio x3.51.3 266.7%  
Inventory Days Days21754 402.9%  
Debtors Days Days8162 130.0%  
Net fixed assets Rs m1,62447,896 3.4%   
Share capital Rs m5341,024 52.2%   
"Free" reserves Rs m5,96048,746 12.2%   
Net worth Rs m7,40453,519 13.8%   
Long term debt Rs m1048,964 1.2%   
Total assets Rs m8,010100,163 8.0%  
Interest coverage x950.744.7 2,124.4%   
Debt to equity ratio x00.2 8.4%  
Sales to assets ratio x0.21.0 16.0%   
Return on assets %29.315.7 186.5%  
Return on equity %31.628.4 111.2%  
Return on capital %31.334.3 91.2%  
Exports to sales %2.945.3 6.5%   
Imports to sales %28.95.9 486.3%   
Exports (fob) Rs m3744,537 0.1%   
Imports (cif) Rs m3645,838 6.2%   
Fx inflow Rs m3744,881 0.1%   
Fx outflow Rs m3659,069 4.0%   
Net fx Rs m-32835,812 -0.9%   
CASH FLOW
From Operations Rs m34619,938 1.7%  
From Investments Rs m-48-9,039 0.5%  
From Financial Activity Rs m-301-9,527 3.2%  
Net Cashflow Rs m-31,372 -0.2%  

Share Holding

Indian Promoters % 64.0 74.8 85.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 8.3 2.4%  
FIIs % 9.7 5.9 164.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 11.0 237.3%  
Shareholders   54,701 44,069 124.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   BIOCON LTD  WOCKHARDT LTD.  AUROBINDO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  

Compare ALEMBIC LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 22, 2017 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS